Pulse Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.08.24	Weekly Review: ANTX Downsizes, ALDX Aces Dry Eye Disease Trial, FDA Oks 1st Epinephrine Nasal Spray (RTTNews)
08.07.24	Pulse Biosciences Announces Breakthrough Device Designation For Cardiac Surgery System (RTTNews)
09.03.24	Pulse Biosciences Gets FDA 510(k) Clearance For CellFX NsPFA Percutaneous Electrode System (RTTNews)
14.02.24	Pulse Biosciences Announces Positive Results For CellFX NsPFA 360 Cardiac Catheter Study; Stock Up (RTTNews)
21.11.23	Pulse Biosciences Files 510(k) Submission With FDA For Its CellFX NsPFA (RTTNews)
13.11.23	Pulse Biosciences, Inc. (PLSE) Q3 Loss Drops (RTTNews)
29.03.23	Ausblick: Pulse Biosciences verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
15.03.23	Erste Schätzungen: Pulse Biosciences mit Zahlen zum abgelaufenen Quartal (finanzen.net)
09.11.22	Ausblick: Pulse Biosciences mit Zahlen zum abgelaufenen Quartal (finanzen.net)
26.09.22	Pulse Biosciences Receives FDA Clearance For The Treatment Sebaceous Hyperplasia (RTTNews)
15.04.22	PLSE DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - PLSE (PR Newswire)
07.04.22	PLSE DEADLINE ALERT: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors to Secure Counsel Before Important April 18 Deadline in Securities Class Action - PLSE (PR Newswire)
07.04.22	Pre-market Movers: ERYP, IVDA, VAPO, SST, RAD… (RTTNews)
28.03.22	ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses To Secure Counsel Before Important April 18 Deadline In Securities Class Action - PLSE (PR Newswire)
22.03.22	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE (PR Newswire)
13.03.22	ROSEN, A LEADING LAW FIRM, Encourages Pulse Biosciences, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - PLSE (PR Newswire)
05.03.22	ROSEN, A LEADING LAW FIRM, Encourages Pulse Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLSE (PR Newswire)
22.02.22	ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PLSE (PR Newswire)
15.02.22	Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer (Businesswire)
08.02.22	Pulse Biosciences : FDA Didn't Accept 510(k) Submission On Sebaceous Hyperplasia Treatment (RTTNews)
08.02.22	Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission (Businesswire)
01.02.22	Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Businesswire)
11.01.22	Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results (Businesswire)
01.10.20	Pulse Biosciences Initiates Pivotal Study Of CellFX System In Sebaceous Hyperplasia (RTTNews)
11.09.20	AVXL On Watch, STSA Reels With Pain As Migraine Study Fails, HSTO To Report Alopecia Data In Q4 (RTTNews)
11.06.19	NBY To Sell Lash Spray On Amazon, PRVB Proves Mettle, CVM Catches Eyes (RTTNews)
26.10.18	FATE Catches Eyes, LJPC Upbeat, CLSD To Submit XIPERE NDA By Year-end (RTTNews)
21.08.18	LCI Whacked On Contract Loss, CWBR Awaits Data, Busy Months Ahead For PLSE (RTTNews)
31.07.18	LXRX On Watch, NKTR To Face FDA In May, TNDM Boosts Sales Outlook (RTTNews)
13.04.18	FDA Nod For Innovus' Kit, PLSE Soars On SK Data, Keep An Eye On ARNA (RTTNews)
12.09.17	Keep Close Watch On ALDX Today, ABBV Just Hit Another High, Fennec Uplisted (RTTNews)
11.09.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE) (PR Newswire)
28.07.17	The Big Deal About Stem Cell Therapies and Regenerative Medicine (PR Newswire)
28.07.17	The Big Deal About Stem Cell Therapies and Regenerative Medicine (PR Newswire)
21.07.17	Congress Could Have Major Impact on Biotech Companies (PR Newswire)
21.07.17	Congress Could Have Major Impact on Biotech Companies (PR Newswire)
21.07.17	Congress Could Have Major Impact on Biotech Companies (PR Newswire)
21.07.17	Congress Could Have Major Impact on Biotech Companies (PR Newswire)
09.05.17	Kerrisdale Capital Issues Negative Report on Pulse Biosciences, Inc. and Announces Conference Call (PR Newswire)
18.04.17	Gainers & Losers Of Apr.17: CBLI, INFI, PBYI, OMED, INCY... (RTTNews)
13.04.17	Gainers & Losers Of Apr.12: ADPT, NBIX, NOVN, PLX, ALBO... (RTTNews)
12.04.17	Gainers & Losers Of Apr.11: WINT, GNCA, MESO, CYTX, ENDP... (RTTNews)
07.04.17	Gainers & Losers Of Apr.6: HTGM, AKTX, FGEN, ARLZ, ADAP... (RTTNews)
31.03.17	Gainers & Losers Of Mar.30: XBIO, PRAN, AKER, TNXP, HALO... (RTTNews)
17.03.17	Gainers & Losers Of Mar.16: MCRB, PLSE, OCUL, PTCT, TROV... (RTTNews)
15.03.17	FDA Panel Snubs ENDP, Watch Out For TCON, MRK's Keytruda Scores Another Win (RTTNews)
14.03.17	Gainers & Losers Of Mar.13: ALIM, AEMD, VSTM, ARLZ, OSIR... (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	121.85	2.78 %	K V
Lonza Grp	528.00	1.27 %	K V
Logitech Intl	71.88	1.21 %	K V
Swiss Re	129.85	1.21 %	K V
UBS Group	28.38	0.28 %	K V
ABB	49.88	-0.56 %	K V
Swiss Life Hldg	728.00	-0.76 %	K V
Givaudan	3’900.00	-0.84 %	K V
Novartis	92.30	-1.47 %	K V
Sonova Hldg	306.30	-1.86 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pulse Biosciences Inc

Aktien Top/Flop

Meistgelesene Nachrichten